ReviewJournal of cancer research and clinical oncology2017

Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Mukundan Baskar Mannargudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.